核酸
胶质母细胞瘤
免疫疗法
肿瘤微环境
免疫系统
癌症研究
癌症
生物
医学
免疫学
计算生物学
遗传学
生物化学
作者
Lauren Dain,Guizhi Zhu
标识
DOI:10.1016/j.ijpharm.2023.122924
摘要
Glioblastoma multiforme (GBM) is a deadly and difficult to treat primary brain tumor for which satisfactory therapeutics have yet to be discovered. While cancer immunotherapeutics, such as immune checkpoint inhibitors, have successfully improved the treatment of some other types of cancer, the poorly immunogenic GBM tumor cells and the immunosuppressive GBM tumor microenvironment have made it difficult to develop GBM immunotherapeutics. Nucleic acids therapeutics and vaccines, particularly those of mRNA, have become a popular field of research in recent years. This review presents the progress of nucleic acid therapeutics and vaccines for GBM and briefly covers some representative delivery methods of nucleic acids to the central nervous system (CNS) for GBM therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI